Log In
Print this Print this

carotuximab (IV TRC105)

  Manage Alerts
Collapse Summary General Information
Company Tracon Pharmaceuticals Inc.
DescriptionHuman chimeric mAb against endoglin (CD105; ENG)
Molecular Target Endoglin (CD105) (ENG)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today